Cargando…

Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells

TAB182 participates in DNA damage repair and radio-/chemosensitivity regulation in various tumors, but its role in tumorigenesis and therapeutic resistance in breast cancer remains unclear. In the current paper, we observed that triple-negative Breast Cancer (TNBC), a highly aggressive type of breas...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Huan, Wang, Shaozheng, Zhang, Wen, Gao, Shanshan, Guan, Hua, Zhou, Pingkun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642046/ https://www.ncbi.nlm.nih.gov/pubmed/37953246 http://dx.doi.org/10.1186/s12885-023-11552-4

Ejemplares similares

TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer
por: Tao, Tao, et al.
Publicado: (2016)

Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation
por: Cao, Yuandong, et al.
Publicado: (2021)

MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer
por: Zhang, Xingzeng, et al.
Publicado: (2017)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells
por: Yin, Shuping, et al.
Publicado: (2017)

Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts
por: Nakayama, Jun, et al.
Publicado: (2022)

Downregulation of fascin induces collective cell migration in triple‑negative breast cancer
por: Yamamoto, Yumiko, et al.
Publicado: (2023)

TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner
por: Gao, Aidi, et al.
Publicado: (2022)

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)

Kruppel-like factor 8 regulates triple negative breast cancer stem cell-like activity
por: Le Minh, Giang, et al.
Publicado: (2023)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer
por: Satriyo, Pamungkas Bagus, et al.
Publicado: (2019)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
por: Wang, Yuyi, et al.
Publicado: (2018)

Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer
por: Sun, Huizhi, et al.
Publicado: (2019)

Correction: TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner
por: Gao, Aidi, et al.
Publicado: (2023)

Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7
por: Wu, Xingping, et al.
Publicado: (2020)

Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer
por: Bajaj, Rajat, et al.
Publicado: (2020)

MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer
por: Dinami, Roberto, et al.
Publicado: (2022)

Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
por: Yang, Fang, et al.
Publicado: (2016)

Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells
por: Ramamoorthy, Prabhu, et al.
Publicado: (2021)

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
por: Olsson, Maxim, et al.
Publicado: (2023)

Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells
por: Liu, Chun-Yu, et al.
Publicado: (2019)

TAB2 Promotes the Stemness and Biological Functions of Cervical Squamous Cell Carcinoma Cells
por: Zhou, Yijia, et al.
Publicado: (2021)

HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer
por: Li, Xiaoying, et al.
Publicado: (2021)

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer
por: Brisard, Daphne, et al.
Publicado: (2018)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer
por: Zhao, Zitong, et al.
Publicado: (2019)

Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
por: Li, Ying-Wei, et al.
Publicado: (2018)

jmzTab: A Java interface to the mzTab data standard
por: Xu, Qing-Wei, et al.
Publicado: (2014)

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
por: Lee, Kha-Liang, et al.
Publicado: (2019)

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

Downregulation of circ-Foxo3 in breast cancer stem-like cells
por: Kamalabadi-Farahani, Mohammad, et al.
Publicado: (2023)

Keeping tabs on fructose
por: Shalev, Anath
Publicado: (2016)

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
por: Zhao, Zitong, et al.
Publicado: (2023)

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
por: Liu, Mingshan, et al.
Publicado: (2018)

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2017)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
por: He, Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ehcr9nblp0frop7mcflskd7qs